Page last updated: 2024-08-16

troglitazone and 2,2'-azobis(2-amidinopropane)

troglitazone has been researched along with 2,2'-azobis(2-amidinopropane) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaku, K; Kaneko, T; Nagasaka, Y; Nakamura, K	1

Other Studies

1 other study(ies) available for troglitazone and 2,2'-azobis(2-amidinopropane)

Article	Year
The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro. Biochemical pharmacology, 1995, Sep-28, Volume: 50, Issue:7 Topics: Administration, Oral; Amidines; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Thiazoles; Thiazolidinediones; Thiobarbituric Acid Reactive Substances; Time Factors; Troglitazone; Vitamin E	1995

Article

Year

The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro.

Biochemical pharmacology, 1995, Sep-28, Volume: 50, Issue:7

Topics: Administration, Oral; Amidines; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Thiazoles; Thiazolidinediones; Thiobarbituric Acid Reactive Substances; Time Factors; Troglitazone; Vitamin E

1995